Literature DB >> 1663461

The relative potency of pentobarbital in suppressing the kainic acid- or the N-methyl-D-aspartic acid-induced enhancement of cGMP in cerebellar cells.

W W Morgan1, J Bermudez, X Y Chang.   

Abstract

Primary cultures of rat cerebellar cells were pretreated with various dosages of pentobarbital before the addition of kainic acid or N-methyl-D-aspartic acid in order to assess effects of this drug on the enhancement of cyclic guanosine-3',5'-phosphate (cyclic GMP) mediated by these excitatory agonists. Pentobarbital significantly suppressed kainic acid-induced increases in this cyclic nucleotide at concentrations as low as 5 microM but was only effective in suppressing the N-methyl-D-aspartic acid enhancement at dosages of 100 microM or greater. These data suggest that this barbiturate is a more effective depressant of the stimulatory effects of kainic acid as compared to N-methyl-D-aspartic acid.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1663461     DOI: 10.1016/0014-2999(91)90861-j

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  A Fatal Adverse Effect of Barbiturate Coma Therapy: Dyskalemia.

Authors:  Hyun Mook Kwon; Jin Wook Baek; Sang Pyung Lee; Jae Ik Cho
Journal:  Korean J Neurotrauma       Date:  2016-10-31

2.  Role of NMDA receptors in pentobarbital tolerance/dependence.

Authors:  S Oh; K Hoshi; I K Ho
Journal:  Neurochem Res       Date:  1997-07       Impact factor: 3.996

3.  The effect of barbiturate coma therapy for the patients with severe intracranial hypertension: a 10-year experience.

Authors:  Young-Il Kim; Seung-Won Park; Taek-Kyun Nam; Yong-Sook Park; Byung-Kook Min; Sung-Nam Hwang
Journal:  J Korean Neurosurg Soc       Date:  2008-09-30

4.  Changes in NMDAR2 subunit mRNA levels during pentobarbital tolerance/withdrawal in the rat brain: an in situ hybridization study.

Authors:  C G Jang; S Oh; I K Ho
Journal:  Neurochem Res       Date:  1998-11       Impact factor: 3.996

5.  Early prediction of neurological outcome after barbiturate coma therapy in patients undergoing brain tumor surgery.

Authors:  Jeong-Am Ryu; Wonkyung Jung; Yoo Jin Jung; Do Yeon Kwon; Kina Kang; Hyeok Choi; Doo-Sik Kong; Ho Jun Seol; Jung-Il Lee
Journal:  PLoS One       Date:  2019-04-17       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.